Experimental compounds have demonstrated the ability to stop up to 90% of pancreatic cancer cell migration and trigger self-destruction in laboratory settings, according to research reported by ScienceDaily and Medical …
-
-
Animal rights activists staged a protest in Madrid, Spain, wearing black clothing, horns, and red paint to simulate blood to denounce the livestock industry. The demonstrators gathered to highlight the …
-
Health
Revolutionizing Nutrition: How Wearables, AI, and Personalization Are Changing Health Tracking in Singapore
How AI and Wearables Are Reshaping Personalized Nutrition in Singapore Singapore-based Nutricode, a company specializing in AI-driven health solutions, has announced a new phase in personalized nutrition that leverages wearable …
-
Scientists Identify Vulnerability in Deadly Gut Bacteria, Offering New Treatment Pathways Researchers have identified a potential “Achilles’ heel” in antibiotic-resistant gut bacteria, according to a study published in Nature Microbiology …
-
Peru’s Detecta Clínica Introduces Minimally Invasive Sentinel Lymph Node Biopsy for Breast Cancer Patients Peru’s Detecta Clínica has implemented a novel approach to breast cancer surgery, utilizing indocyanine green and …
-
Researchers in Brazil Enhance Cancer Immunotherapy with Engineered Natural Killer Cells Scientists at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) in Brazil have developed a …
-
Ebola clinical trials in the Democratic Republic of the Congo (DRC) focus on refining vaccines and monoclonal antibody treatments to reduce mortality rates during active outbreaks. According to the World …
-
Uterine Aging and Donor Egg Pregnancy Success After 49 Pregnancy success rates for women using donor eggs decline after age 49 because the uterus undergoes biological aging regardless of the …
-
Argentine wheat producers are adjusting planting dates and cultivar choices due to recent heavy rains and soil humidity, according to reports from Aapresid. How are humidity and planting delays affecting …
-
The FDA has declined to approve Galderma’s biologics license application for relabotulinumtoxinA, citing manufacturing and testing concerns. According to a company press release, the agency issued a complete response letter …
Newer Posts